Pharmacokinetics, Immunogenicity and Safety Study for SHR-1309 Injection and Perjeta® in Healthy Chinese Male Volunteers

• Egile Nagusiak: Yingzi Cui (Egilea), Dongyang Cui (Egilea), Xinran Ren (Egilea), Xuesong Chen (Egilea), Guangwen Liu (Egilea), Zhengzhi Liu (Egilea), Yanli Wang (Egilea), Xinyao Qu (Egilea), Yicheng Zhao (Egilea), Haimiao Yang (Egilea)
• Formatua: Liburua
• Argitaratua: Frontiers Media S.A., 2021-06-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Objectives: Pertuzumab is a monoclonal antibody for the treatment of breast cancer. The aim of this study was to compare the pharmacokinetics, immunogenicity and safety of the test preparation SHR-1309 injecta and the reference preparation Perjeta® in healthy Chinese male subjects.Methods: In this r...